ALT shares drop over 20% after updated pemvidutide week 48 data; see FDA's stance on non-invasive fibrosis tests. Click here ...

When methadone clinics close over the holidays, the consequences can be devastating for patients, writes Dr. Dustin Kee.

Many are familiar with CPAP machines to treat sleep apnea, but fewer realize an oral appliance is an effective alternative. So how do you know if you’re a good candidate?

Stifel analysts said the label for cardiac myosin inhibitor Myqorzo is in line with their expectations and is differentiated compared with BMS’ Camzyos.

Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved once-daily Wegovy (R) pill, the first oral GLP-1 medicine for obesity in the US. (3) Wegovy (R) pill is used ...

Unless such surprises materialize, analysts like Phipps see the Dynavax story as largely written, with most of the remaining upside and downside bounded by Sanofi’s $15.50 per share offer. Inhibikase ...

Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved once-daily Wegovy® pill, the first oral GLP-1 medicine for obesity in the US.3 Wegovy® pill is used with a ...

Procrastination isn’t laziness. It is overwhelm, avoidance, and the human brain trying to dodge discomfort. With tiny steps, ...

RIKEN researchers have discovered how right-handed molecules in our cells can give rise to cells that are not symmetrical ...

If your New Year's resolution is to start resistance training, Life Kit is here to help. Sign up for our Guide to Building ...

ARDS is a life-threatening lung condition causing severe breathing failure. New research shows AI could personalize ...

Altimmune's pemvidutide shows strong Phase IIb results for MASH, promising Phase III prospects. Read here for more analysis ...